Helix BioPharma Corp HBPCF
$1.71
Last Updated: May 18, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
HBPCF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Helix BioPharma Corp is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Helix BioPharma Corp. Stock Analysis HBPCF
United States Health Care Micro Cap Helix BioPharma Corp. is an immuno-oncology company, which engages in the development of products for the treatment and prevention of cancer. The company is headquartered in Toronto, Ontario. The Company’s pipeline is led by Tumor Defense Breaker L-DOS47, a clinical-stage antibody-enzyme conjugate designed to prime CEACAM6-expressing tumors for increased sensitivity to therapy. L-DOS47 has completed Phase Ib studies in non-small cell lung cancer (NSCLC) and shares its CEACAM6-targeting foundation with the Company's next-generation bi-specific antibody-drug conjugates (ADCs), in discovery. The firm is also advancing two pre-IND candidates: LEUMUNA, an oral immune checkpoint modulator aimed at achieving durable remission in post-transplant leukemia relapse, and GEMCEDA, an oral gemcitabine prodrug with bioavailability on a par with IV, designed to expand treatment options for advanced cancers.
Helix BioPharma Corp (HBPCF) Chart
Financial Metrics & Statements of Helix BioPharma Corp (HBPCF)
FAQ's for Helix BioPharma Corp (HBPCF)
- As of August 2026, Helix BioPharma Corp HBPCF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Helix BioPharma Corp using these criteria to determine its compliance status.
- Muslim investors may consider investing in Helix BioPharma Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Helix BioPharma Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Helix BioPharma Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Helix BioPharma Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Helix BioPharma Corp (HBPCF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
